scispace - formally typeset
Open AccessJournal ArticleDOI

Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases.

TLDR
An overview of the roles of microglia-mediated neuroinflammation in major retinal degenerative diseases like glaucoma, age-related macular degeneration, and diabetic retinopathy is given.
Abstract
Retinal degenerative diseases are major causes of vision loss and blindness worldwide and are characterized by chronic and progressive neuronal loss. One common feature of retinal degenerative diseases and brain neurodegenerative diseases is chronic neuroinflammation. There is growing evidence that retinal microglia, as in the brain, become activated in the course of retinal degenerative diseases, having a pivotal role in the initiation and propagation of the neurodegenerative process. A better understanding of the events elicited and mediated by retinal microglia will contribute to the clarification of disease etiology and might open new avenues for potential therapeutic interventions. This review aims at giving an overview of the roles of microglia-mediated neuroinflammation in major retinal degenerative diseases like glaucoma, age-related macular degeneration, and diabetic retinopathy.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Microglia in Retinal Degeneration.

TL;DR: This review provides an overview of recent studies that depict microglial responses in diverse retinal pathologies that have degeneration and chronic immune reactions as key pathophysiological components and discusses innovative immunomodulatory therapy strategies that dampen the detrimental immunological responses to improve disease outcome.
Journal Article

Suppression of Diabetic Retinopathy with Angiopoietin-1

TL;DR: Angiopoietin-1 is identified as the first naturally occurring protein that directly protects the retinal vasculature in diabetes and is shown to prevent and reverse diabetic retinal vascular changes in both new and established diabetes.
Journal ArticleDOI

PINK1/PARKIN signalling in neurodegeneration and neuroinflammation.

TL;DR: The role of mitochondrial dysfunction in disorders such as amyotrophic lateral sclerosis, Alzheimer's, Huntington’s and Parkinson's diseases, as well as eye diseases such as age-related macular degeneration and glaucoma, and the causative factors leading to PINK1/PARKIN-mediated neurodegeneration and neuroinflammation are debated.
Journal ArticleDOI

Neuroprotective effects of chrysin: From chemistry to medicine

TL;DR: The present paper aimed to critically review the available literature data regarding the neuroprotective effects of chrysin as well as its chemistry, sources and bioavailability.
References
More filters
Journal ArticleDOI

Diagnosis and Classification of Diabetes Mellitus

Vittorio Basevi
- 06 Feb 2011 - 
TL;DR: The chronic hyperglycemia of diabetes is associated with long-term damage, dys-function, and failure of differentorgans, especially the eyes, kidneys, nerves, heart, and blood vessels.
Journal ArticleDOI

Biologic basis for interleukin-1 in disease

TL;DR: This is a lengthy review, with 586 citations chosen to illustrate specific areas of interest rather than a compendium of references, which summarizes what the author considers established or controversial topics linking the biology of IL-1 to mechanisms of disease.
Journal ArticleDOI

Global data on visual impairment in the year 2002

TL;DR: Estimates from data on low vision and blindness as defined in the International statistical classification of diseases, injuries and causes of death, 10th revision show cataract remains the leading cause of visual impairment in all regions of the world, except in the most developed countries.
Journal ArticleDOI

Nitric oxide synthases: regulation and function.

TL;DR: Nitric oxide (NO), the smallest signalling molecule known, is produced by three isoforms of NO synthase (NOS), which can be expressed in many cell types in response to lipopolysaccharide, cytokines, or other agents.
Related Papers (5)